Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Half-Life of the Truth

Philip Seo, MD, MHS  |  Issue: July 2020  |  July 15, 2020

The pipe organ in Wanamaker's department store, Philadelphia.

The pipe organ in Wanamaker’s department store, Philadelphia.
Dmitry Br / shutterstock.com

When I was in training, blood trans­fusions for anemia were common. We referred to it as “tanking the patient up,” as if it were a service, such as checking the oil or cleaning the windows. Any patient who was admitted with cardiac ischemia would be discharged with a hemoglobin of 10 g/dL, automatically. It was just good medicine.

Until it wasn’t. The Transfusion Requirements in Clinical Care (TRICC) investigators decided to challenge this practice by conducting a study in which critically ill patients were randomized to different transfusion goals. Half the patients were transfused to a goal of 10 g/dL, and half the patients were transfused to a goal of 7 g/dL.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

What followed was a game-changer. Contrary to the popular wisdom, critically ill patients who were transfused to the higher goal hemoglobin did not have a reduction in mortality. In fact, patients who were younger or less ill fared better if we just left them alone. Subsequent studies tried and failed to find subgroups who routinely benefited from an aggressive trans­fusion strategy until it became clear: The common wisdom was wrong.

Hence, we come to the cause of the laughter.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

When talking to patients, I always describe ischemic digits as akin to having a heart attack of the hand—part of their body is screaming for oxygen. Given this, I was wondering if this patient, with her history of anemia, might benefit from a blood transfusion, to increase her perfusion pressure.

I knew that no such studies existed in scleroderma patients, but I knew someone must have studied this in patients with myocardial ischemia. It has been years since I have practiced internal medicine regularly, so I asked my fellow: Had the findings of the TRICC study been replicated in patients with acute coronary syndromes?

And she laughed at me.

She later explained that she had never heard of the TRICC study referred to by name. The original study was published in the New England Journal of Medicine when she was still in grade school. It was as if she had knocked a glass off a table, and I had referred her to a passage in Principia. No one referred to the study anymore. It was just fact.

If she only knew.

The Truth & Other Myths

I have been alive long enough that I have lived through many versions of the truth. I feel most betrayed by the estrogen story: When I was in medical school, estrogens were thought to be the fountain of youth, the reason why women had fewer heart attacks and strokes than men. Post-menopausal women could continue to experience these benefits if they started to take estrogen supplements, which became an integral part of primary cardiac prophylaxis, as integral as taking an aspirin.

When I was in residency, the story changed. The Women’s Health Initiative demonstrated that estrogens actually increased the rates of heart attacks and strokes among post-menopausal women.2 Because this occurred during my training, I vividly remember the denial that took place around the time the Women’s Health Initiative published its findings. The cohort was skewed. The intervention was wrong.

It was only years later, after much wailing and gnashing of teeth, that we finally became comfortable with the truth: The common wisdom was wrong. My personal takeaway? Thank God my mother never listens to me. When I was in medical school, egged on by my august professors, I harangued her about taking supplemental estrogen. In retrospect, if she had actually started taking Premarin on my say-so, I’m not sure I would have ever forgiven myself.

She also never started taking a baby aspirin, even though everyone knew that it would prevent myocardial infarctions. At least we knew it until a few years ago, when we learned that women with no history of heart disease, like my mother, actually didn’t benefit from taking an aspirin, after all.3

As an aside, I have little patience for the practitioners of revisionist history. I have sat through many lectures that have described why we should have known that estrogens or aspirin or whatever was just snake oil, and if we had looked at the older data in just the right light, the truth would have shown through clearly.

Hogwash. I am old enough that I have borne witness as, again and again, heresy has become scripture and scripture has been dismissed as myth. I can testify that many of the experts who speak with such confidence were saying very different things a decade or two ago, with an equal amount of confidence.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Education & TrainingOpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:Research

Related Articles

    Drug Commercials—How Are They Still a Thing?

    July 19, 2018

    Picture this: It’s 3 o’clock in the morning. You can’t sleep. You settle in front of the television to watch a rerun of Dirty Dancing. And then it hits you: Ask your doctor. Even as your eyelids sag, some part of your primitive forebrain snaps to attention. Medical training has turned us all into multitaskers,…

    Are Your Ads Violating the Law?

    January 13, 2012

    While advertising is a great way to promote your practice, be sure to avoid legal pitfalls

    Pharma awaits FDA Guidance to Navigate the Murky Waters of Ads Via the Internet and Social Media

    November 1, 2010

    There’s no question that direct-to-consumer (DTC) advertising of prescription drugs is a huge activity, with nearly $5 billion spent on DTC ads in 2007. There’s also no question that the Internet has a vast potential to reach consumers. But when you put DTC advertising and the Internet together, there is a potential for problems and…

    Rheuminations: Epigenetics May Help to Explain Why Some Get Rheumatic Disease

    March 1, 2013

    Recent research around genes and environmental stresses suggests outside influences can make lasting changes to the genome via epigenetic mechanisms

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences